Kobo Biotech share price
You have to be logged in to add this to Watchlist.- ₹2.72(0.37%)May 19, 2025 13:12:45 PM IST
- NSE
- BSE
- Vol : 1.15K (NSE + BSE)Last 20 day avg : 4.58 K
Kobo Biotech is trading 0.37% upper at Rs 2.72 as compared to its last closing price. Kobo Biotech has been trading in the price range of 2.74 & 2.72. Kobo Biotech has given -37.56% in this year & 0.00% in the last 5 days. The company posted a net profit of -1.33 Crores in its last quarter.Listed peers of Kobo Biotech include Hindustan Bio Sciences (4.96%), Ganga Pharmaceuticals (-%), Kobo Biotech (0.37%).The Mutual Fund holding in Kobo Biotech was at -% in . The MF holding has - from the last quarter. The FII holding in Kobo Biotech was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on May 19, 2025, 09:47 PM UTC
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/EHigher than historical values0.00Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.84Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Debt To Equity-The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is not profitable- The company has increased its June quarter loss by 8.47% from Rs 1.23 crore to Rs 1.33 crore, year-on-year
- Earnings are insufficient to cover the interest expenses on outstanding debt
- R1
- 3.01
- R2
- 3.25
- R3
- 3.46
- S1
- 2.56
- S2
- 2.35
- S3
- 2.11
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Hindustan Bio Sciences | Neutral | 8.04 | 4.96 | 8.24 | 136.35 | 9.76 | - | 317.88 |
| Ganga Pharmaceuticals | Moderately Bearish | 13.51 | - | 6.53 | 191.60 | 0.93 | - | 5.60 |
| Kobo Biotech | Bearish | 2.72 | 0.37 | 6.48 | - | - | - | |
| Brawn Biotech | Neutral | 17.83 | 2.89 | 5.35 | - | 1.03 | - | - |
| Hemo Organic | Neutral | 9.69 | 5.90 | 3.36 | - | - | - |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2024-08-14 | Quarterly Results |
| 2024-05-30 | Audited Results |
| 2024-02-14 | Quarterly Results |
| 2023-11-10 | Quarterly Results |
| 2023-08-11 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE881A01015
- BSE Code531541
- NSE Code
Kobo Biotech is trading at 2.72 as on Mon May 19 2025 07:42:45. This is 0.37% upper as compared to its previous closing price of 2.71.
The market capitalization of Kobo Biotech is 6.48 Cr as on Mon May 19 2025 07:42:45.
The 52 wk high for Kobo Biotech is 5.11 whereas the 52 wk low is 2.51
Kobo Biotech can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: 24.50
- Dividend Yield: 0.00%
- D/E ratio: -
Kobo Biotech reported a net profit of -4.93 Cr in 2024.